Zobrazeno 1 - 4
of 4
pro vyhledávání: '"William Pletcher"'
Autor:
Cynthia D. Johnson, J. McClean, William Pletcher, Rudolph M. Navari, Lawrence H. Einhorn, Steven D. Passik, Jake Vinson, Patrick J. Loehrer, Mary Lou Mayer
Publikováno v:
Supportive Care in Cancer. 13:529-534
In a previous phase I study, olanzapine was demonstrated to be a safe and effective agent for the prevention of delayed emesis in chemotherapy-naïve cancer patients receiving cyclophosphamide, doxorubicin, and/or cisplatin. Using the maximum tolerat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::284f3c9dec20588df871f783b4a9c0db
https://doi.org/10.1007/s00520-004-0755-6
https://doi.org/10.1007/s00520-004-0755-6
Autor:
Joanne E. Mortimer, Patrick J. Loehrer, René Gonin, Kathy D. Miller, William Pletcher, C. H. Spiridonidis, George Weber, Rafat Ansari, John McClean
Publikováno v:
Investigational New Drugs. 14:207-212
From January 1992 through May 1993, 31 patients with adenocarcinoma of the pancreas or hepatocellular carcinoma were treated with weekly oral methotrexate (7.5 mg/M2 every 6 hours for 6 doses) and continuous oral AZT (200 mg four times daily). Patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebb20d05329835d91e4790f48883fda3
https://doi.org/10.1007/bf00210792
https://doi.org/10.1007/bf00210792
Autor:
Paul R. Helft, Jake Vinson, Patrick J. Loehrer, William Pletcher, D. Seitz, Christopher Sweeney, Liang Cheng, Beth E. Juliar, Rafat Ansari, Chong-Xian Pan
Publikováno v:
Oncology. 69(1)
Objectives: Preclinical and clinical data indicate that cyclooxygenase-2 (COX-2) is a bona fide molecular target for colorectal cancer (CRC). Glutamine may decrease chemotherapy-associated diarrhea. This study was designed to address whether the addi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c72af4b94b9fe17df49666e38c7e1240
https://pubmed.ncbi.nlm.nih.gov/16088234
https://pubmed.ncbi.nlm.nih.gov/16088234
Autor:
Sumeet Bhatia, Elizabeth Ng, William Pletcher, Nasser H. Hanna, Rafat Ansari, Lawrence H. Einhorn, Alan Sandler
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 38(1)
Platinum-based combination chemotherapy has become the standard treatment for good performance patients with stage IIIb and IV non-small cell lung cancer (NSCLC). However, newer agents such as gemcitabine and paclitaxel appear to have superior single
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b80e0aecc8abb527549f8dd008980041
https://pubmed.ncbi.nlm.nih.gov/12367796
https://pubmed.ncbi.nlm.nih.gov/12367796